Colorectal cancer incidence is increasing among young adults
the ONA take:
Screening efforts have resulted in an overall decrease in incidence of colorectal cancer (CRC). However, incidence of the disease in young adults (ages 20-39 years) has increased in the past 20 to 30 years.
Little is known about CRC incidence in young adults because recommended screening for people of average risk person begins at age 50 years. Researchers at the University of California, Irvine, analyzed 231,544 CRC cases from 1988-2009 from the California Cancer Registry to identify high-risk subgroups.
Their study cases included 5,617 young adults ages 20-39 years. Although the absolute incidence of CRC per 100,000 in this group was low, the researchers found CRC incidence increasing over time among both males and females, particularly for distal colon cancer in Hispanic females ages 20-29 years.
The researchers conclude that absolute incidence of CRC is significantly lower in among the young adult populations; however, incidence is increasing among young adults compared with the older screened population. They also note a need for further research to better characterize young adults at increased risk for CRC.
Incidence of colorectal cancer in young adults has increased in the past 20 to 30 years.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|